A Phase 1 Trial of Highly Conformal, Hypofractionated Postprostatectomy Radiation Therapy.

Saved in:
Bibliographic Details
Title: A Phase 1 Trial of Highly Conformal, Hypofractionated Postprostatectomy Radiation Therapy.
Authors: Patel KR; Radiation Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland., Rowe LS; Radiation Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland., Schott E; Radiation Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland., Cooley-Zgela T; Radiation Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland., Ning H; Radiation Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland., Turkbey B; Molecular Imaging Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland., Choyke P; Molecular Imaging Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland., Lindenberg L; Molecular Imaging Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland., Mena E; Molecular Imaging Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland., Pinto PA; Urologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland., Zhang Q; Division of Cancer Treatment and Diagnosis: Biometric Research Program, National Cancer Institute, National Institutes of Health, Rockville, Maryland., Shih J; Division of Cancer Treatment and Diagnosis: Biometric Research Program, National Cancer Institute, National Institutes of Health, Rockville, Maryland., Salerno KE; Radiation Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland., Citrin DE; Radiation Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
Source: Advances in radiation oncology [Adv Radiat Oncol] 2022 Jul 15; Vol. 7 (6), pp. 101024. Date of Electronic Publication: 2022 Jul 15 (Print Publication: 2022).
Publication Type: Journal Article
Journal Info: Publisher: Elsevier Inc Country of Publication: United States NLM ID: 101677247 Publication Model: eCollection Cited Medium: Print ISSN: 2452-1094 (Print) Linking ISSN: 24521094 NLM ISO Abbreviation: Adv Radiat Oncol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2452-1094
DOI:10.1016/j.adro.2022.101024